VENOUS THROMBOEMBOLISM
Clinical trials for VENOUS THROMBOEMBOLISM explained in plain language.
Never miss a new study
Get alerted when new VENOUS THROMBOEMBOLISM trials appear
Sign up with your email to follow new studies for VENOUS THROMBOEMBOLISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a hidden killer be missed in heart failure patients?
Diagnosis Not yet recruitingThis study aims to see if doctors are missing dangerous blood clots in the lungs of patients hospitalized for sudden heart failure. It will compare two approaches across multiple hospitals: usual care versus systematically testing all eligible patients for these clots. The goal i…
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: NA • Sponsor: University Hospital, Angers • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
Can doubling the dose stop deadly clots in trauma patients?
Prevention Not yet recruitingThis study aims to see if a higher dose of a common blood thinner (enoxaparin) is better at preventing dangerous blood clots in the lungs and legs of severely injured patients. It will compare the higher dose against the standard dose in 540 adults admitted to intensive care afte…
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Prevention
Last updated Apr 03, 2026 14:43 UTC
-
Common heart drug could be new shield against Cancer's deadly clots
Prevention Not yet recruitingThis trial aims to see if a daily cholesterol-lowering pill (rosuvastatin) can safely prevent life-threatening blood clots in people with cancer. It will involve 4,000 patients who are at higher risk for clots but are not taking blood thinners. The study compares the statin to a …
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Mar 18, 2026 18:25 UTC
-
Where to inject? study tests best spot for blood thinner in obese patients
Knowledge-focused Not yet recruitingThis study aims to find the best injection site for a common blood thinner medication in severely obese patients. Researchers will compare whether injecting in the arm or abdomen leads to more consistent drug levels in the blood. The goal is to help prevent dangerous blood clots …
Matched conditions: VENOUS THROMBOEMBOLISM
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Apr 04, 2026 03:51 UTC
-
New blood test could spot deadly clot risk in cancer patients
Knowledge-focused Not yet recruitingThis study aims to develop a blood test to predict which cancer patients are most likely to develop dangerous blood clots during chemotherapy. Researchers will track 380 patients with lung, ovarian, pancreatic, or stomach cancer, taking blood samples at four points during their t…
Matched conditions: VENOUS THROMBOEMBOLISM
Sponsor: University of Dublin, Trinity College • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC
-
Tracking tiny patients: major study launches to monitor blood thinner safety in infants
Knowledge-focused Not yet recruitingThis study aims to collect real-world information on how doctors prescribe and use blood-thinning medications (like rivaroxaban) to treat dangerous blood clots in babies and toddlers under 2 years old. Researchers will review the medical records of about 850 children who are alre…
Matched conditions: VENOUS THROMBOEMBOLISM
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC